These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28809443)

  • 41. Disposition and protein binding of valproic acid in the developing rat.
    Haberer LJ; Pollack GM
    Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
    Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
    Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
    Booth CL; Pollack GM; Brouwer KL
    Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.
    Mawasi H; Bibi D; Shekh-Ahmad T; Shaul C; Blotnik S; Bialer M
    Mol Pharm; 2016 Jul; 13(7):2492-6. PubMed ID: 27218460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of Polysorbate 60 on Formulation Properties and Bioavailability of Morin-Loaded Nanoemulsions with and without Low-Saponification-Degree Polyvinyl Alcohol.
    Ikeuchi-Takahashi Y; Kobayashi A; Ishihara C; Matsubara T; Matsubara H; Onishi H
    Biol Pharm Bull; 2018; 41(5):754-760. PubMed ID: 29709912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Teratogenic action of antiepileptic drug: 2-propylpentanoic acid-effects on rat and hamster embryos cultured in vitro].
    Włodarczyk B; Biernacki B; Minta M
    Ginekol Pol; 2001 Dec; 72(12):955-60. PubMed ID: 11883251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing pro-survival factors within whole brain tissue of Sprague Dawley rats via intracerebral administration of modified valproic acid.
    Bates RC; Stith BJ; Stevens KE
    J Pharmacol Sci; 2015 Aug; 128(4):193-201. PubMed ID: 26275469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.
    Đorđević SM; Santrač A; Cekić ND; Marković BD; Divović B; Ilić TM; Savić MM; Savić SD
    Int J Pharm; 2017 Nov; 533(2):421-430. PubMed ID: 28552767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system.
    Ma Y; Li H; Guan S
    Drug Dev Ind Pharm; 2015 Feb; 41(2):177-82. PubMed ID: 25113432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.
    Cheng Y; Liu M; Hu H; Liu D; Zhou S
    AAPS PharmSciTech; 2016 Apr; 17(2):409-17. PubMed ID: 26195071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: development, characterization and in vivo evaluation.
    Sandig AG; Campmany AC; Campos FF; Villena MJ; Naveros BC
    Colloids Surf B Biointerfaces; 2013 Mar; 103():558-65. PubMed ID: 23261580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH; Sawchuk RJ; Eggerth RM
    Neurology; 1983 Feb; 33(2):185-91. PubMed ID: 6401848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.
    Scism JL; Powers KM; Artru AA; Lewis L; Shen DD
    Brain Res; 2000 Nov; 884(1--2):77-86. PubMed ID: 11082489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth.
    Fakhraei Lahiji S; Seo SH; Kim S; Dangol M; Shim J; Li CG; Ma Y; Lee C; Kang G; Yang H; Choi KY; Jung H
    Biomaterials; 2018 Jun; 167():69-79. PubMed ID: 29554482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of intracerebroventricular continuous infusion of valproic acid versus single i.p. and i.c.v. injections in the amygdala kindling epilepsy model.
    Serralta A; Barcia JA; Ortiz P; Durán C; Hernández ME; Alós M
    Epilepsy Res; 2006 Jul; 70(1):15-26. PubMed ID: 16616829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.